MoneyAM MoneyAM
 Home   Log In   Register   Our Services   My Account   Contact   Help 
 Stockwatch   Level 2   Portfolio   Charts   Research   Share Price   Awards   Indices   Market Scan   Company Zone   Traders' Room 
 Funds   Trades   Terminal   Alerts   Heatmaps   News   Stock Screener   Forward Diary   Forex Prices   Director Deals   Investors' Room 
 CFDs   Shares   SIPPs   ISAs   Forex   ETFs   Videos   Comparison Tables   Spread Betting   Broker Notes   Shares Magazine 
You are NOT currently logged in

 
Filter Criteria  
Epic: Keywords: 
From: Time:  (hh:mm) RNS:  MonAM: 
To: Time:  (hh:mm)
Please Note - Streaming News is only available to subscribers to the Active Level and above
 


Sensyne Health forms research collaboration with Bristol Myers Squibb

StockMarketWire.com

Clinical technology company Sensyne Health said it had signed a research collaboration agreement with pharmaceutical group Bristol Myers Squibb.

The collaboration initially would focus on applying Sensyne's machine learning to conduct research into disease progression and patient stratification.

The work would encompass various diseases within the broader group of myeloproliferative neoplasms, a group of rare blood diseases.

No financial terms had been disclosed for the agreement, Sensyne Health said.



Story provided by StockMarketWire.com